Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 712 across all filing types
Latest filing 2023-01-11 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and has a very short length (482 characters). There is no textual content indicating any report, announcement, or detailed information. Given the lack of substantive content and the presence of only placeholders for images, this document does not fit any specific report or announcement category. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2023-01-11 English
Shareholders meeting
Regulatory Filings
2023-01-10 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the intimation under regulation 39(3) of SEBI (LODR) Regulations, 2015. It details the loss of share certificates and issuance of duplicate share certificates for a shareholder. The content is focused on compliance and procedural notification related to share certificates, not financial results, management changes, or other report types. The document length is 4585 characters, which is relatively short and primarily serves as a regulatory compliance notice. This fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2023-01-05 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of a new pharmaceutical product, Lenzetto®, by Themis Medicare Ltd. It references compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, which pertains to disclosure of material events. The content focuses on product details, clinical benefits, and company background, without any financial data, earnings information, or regulatory filings. It is not a financial report, earnings release, management discussion, or any other detailed report type. It is a corporate announcement intended for stock exchanges and investors about a new product launch, which fits the category of a Capital/Financing Update or general corporate announcement. However, since it is specifically a press release about a product launch and not about financing or capital structure changes, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-01-03 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding an intimation under regulation 39(3) of SEBI (LODR) Regulations, 2015. It informs about the loss of share certificate and issuance of duplicate share certificate for a shareholder. The content is a compliance notification related to share certificate handling and does not contain financial data, management discussion, or report publication. It is a regulatory compliance announcement related to shareholding documentation, not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2022-12-28 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It mentions the trading window closure period related to the financial results announcement for the quarter and nine months ended 31st December 2022. The document is a regulatory announcement about insider trading compliance and trading window closure, not a financial report or earnings release itself. It does not contain financial data or results but is an informational notice to the exchanges. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2590 characters), and it is not a report publication announcement or certification but a regulatory compliance notice.
2022-12-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.